Remove Events Remove FDA Remove Public Health
article thumbnail

FDA FHIR Pilot Automates Adverse Events Reporting and Validation with Cedars-Sinai and the VA Through eHealth Exchange

Healthcare IT Today

The following is a guest article by Jay Nakashima, President at eHealth Exchange An FDA project aims to make it as easy as possible for clinicians to report adverse drug events and share important clinical data with public health agencies to investigate the event.

FDA 119
article thumbnail

Understanding the FDA Debarment List

Compliancy Group

One primary aspect of compliance is ensuring you are checking the FDA debarment list to verify that those involved in your operations aren’t essentially banned from working in the drug industry. The purpose of this list is to help businesses stay within compliance with FDA regulations and to safeguard public health.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Type of Salt Should You Buy? Rethinking 1924 Food Fortification Policy in 2024

Bill of Health

by Jessica Samuels For 100 years, food fortification , the practice of deliberately increasing the content of vitamins and minerals in a food, has been essential to combating public health crises. Public Health Service recommended that all women of reproductive age get 400 micrograms (mcg) of folic acid per day.

FDA 100
article thumbnail

Everything You Wanted to Know About Expanded Access but Were Afraid to Ask, Part 1

Bill of Health

Expanded Access is not intended to produce generalizable knowledge; however, it involves reporting of serious adverse events (SAEs) to the entity developing the product (the “sponsor”) and the regulatory agency (the U.S. patients each year. Who qualifies for EA, and how does it work? Full committee review is appropriate.

FDA 237
article thumbnail

Remanufacturing or Servicing of Medical Devices: FDA Issues Final Guidance Providing Additional Clarification

Hall Render

Food and Drug Administration (“FDA”) issued a Final Guidance titled “Remanufacturing of Medical Devices,” clarifying the definition of “remanufacturing” for reusable medical devices in need of maintenance or repair (“Final Guidance”). In May 2024, the U.S. Below are some highlights from the Final Guidance.

FDA 40
article thumbnail

News from the Consumer Technology Association and Withings Further Demonstrates Private Sector’s Role in the Pandemic and Public Health

Health Populi

This week, announcements from the Consumer Technology Association (CTA) and Withings further bolster the case for the private sector bolstering public health in this pandemic…and future ones to come beyond the Age of the Coronavirus. On 27th July, CTA announced the Association’s launch of the Public Health Tech Initiative.

article thumbnail

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

Hall Render

On September 29, 2023, the Food and Drug Administration (“FDA”) announced the issuance of a Notice of Proposed Rulemaking (the “Proposed Rule”) to expand the FDA’s regulatory scope over in vitro diagnostics products (“IVDs”) to specifically address Laboratory Developed Tests (“LDTs”).

FDA 40